Abstract
A longitudinal clinical neurological and electrophysiological follow-up study was carried out on 31 HIV1 seropositive outpatients in the asymptomatic or LAS stages of the infection (CDC II–III).
The results of clinical examination and multimodal evoked potentials (EP) recording showed a high percentage of abnormalities (42% and 39% of cases respectively); in a statistically significant number of subjects these abnormalities were predictive of subsequent immunological deterioration, thus demonstrating the close relationship between neurological and immunological functions in HIV1 infection.
Sommario
Abbiamo eseguito uno studio longitudinale di follow-up neurologico clinico ed elettrofisiologico su 31 pazienti ambulatoriali sieropositivi per anticorpi anti-HIV1, in stadio di infezione asintomatica o di LAS (CDC II–III). I risultati dell'esame clinico e della registrazione dei potenziali evocati multimodali hanno mostrato una elevata percentuale di alterazioni (rispettivamente nel 42% e nel 39% dei soggetti); in un numero di casi statisticamente significativo tali anomalie si sono rivelate predittive di un successivo peggioramento della situazione immunologica, mettendo così in evidenza la stretta correlazione tra stato neurologico ed immunologico nel corso dell'infezione da HIV1.
Similar content being viewed by others
References
Cazzullo C.L., Gala C., Ducati A. et al.:Multimodality evoked potentials in HIV infected subjects: a longitudinal study. Ital. J. Neurol. Sci. 11:481–485, 1990.
Centers for Disease Control:Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR 35:334–9, 1986.
Chiappa K.:Evoked Potentials in clinical medicine. In Baker E.B. and Joynt R.J. Eds. Clinical Neurology. Harper & Row Publishers Philadelphia. Volume 1; Chapter 7, 1985.
Chiodi F., Sonnerborg A., Albert J. et al.:Human Immunodeficiency Virus infection of the brain. I. Virus isolation and detection of HIV specific antibodies in the cerebrospinal fluid of patients with varying clinical conditions. J. Neurol. Sci. 85:245–57, 1988.
Chiodi, F., Norkrans G., Hagberg I. et al.:Human immunodeficiency virus infection of the brain. II. Detection of intrathecally synthesized antibodies by enzyme linked immunosorbent assay and imprint immunofixation. J. Neurol. Sci. 87:37–48, 1988.
Elovaara I., Iivanainen M., Valle S.L. et al.:CSF protein and cellular profiles in various stages of HIV infection related to neurological manifestations. J. Neurol. Sci. 78:331–342, 1987.
Elovaara I., Muller K.M.:Altered cellular immunity of CNS in early stages of HIV1 infection precedes immune abnormalities in the blood. Satellite Conference prior to the VII International Conference on AIDS p. 28 (abstract), 1991.
Goudsmit J., Wolters E.C., Bakker M. et al.:Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex. Br. Med. J. 292:1231–34, 1986.
Grant I., Atkinson, J., Hesselink J. et al.:Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Ann. Intern. Med. 107:828–836, 1987.
Hollander H., Levy J.A.:Neurologic abnormalities and recovery of Human Immunodeficiency Virus from cerebrospinal fluid. Ann. Intern. Med. 106:692–5, 1987.
Janssen R.S., Saykin A.J., Kaplan J.E. et al.:Neurological complications of human immunodeficiency virus infection in patients with lymphadenopathy syndrome. Ann. Neurol. 23:49–55, 1988.
Kaiser R., Dorries R., Luer W. et al.:Analysis of oligoclonal antibody bands against individual HIV structural proteins in the CSF of patients infected with HIV. J. Neurol. 236:157–60, 1989.
Koralnik I.J., Beaumanoir A., Hausler R. et al.:A controlled study of early neurologic abnormalities in men with asymptomatic Human Immunodeficiency Virus infection. N. Engl. J. Med. 323:864–70, 1990.
Levy, J.A.:Human Immunodeficiency Viruses and the pathogenesis of AIDS. JAMA 261:2997–3006, 1989.
McArthur J.C., Cohen B.A., Farzedegan H. et al.:Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings. Ann. Neurol. 23 (suppl.):S34-S37, 1988.
McArthur J.C., Becker P.S., Parisi J.E. et al.:Neuropathological changes in early HIV1 dementia. Ann. Neurol. 26:681–684, 1989.
McArthur, J.C., Cohen B.A., Selnes O.A. et al.:Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1 infected individuals: results from the multicenter AIDS cohort study. Ann. Neurol. 26:601–611, 1989.
Marshall D.W., Brey R.L., Cahill W.T. et al.:Spectrum of cerebrospinal fluid findings in various stages of Human Immunodeficiency Virus infection. Arch. Neurol. 45:954–8, 1988.
Navia B.A., Price R.W.:The Acquired Immunodeficiency Syndrome dementia complex as the presenting or sole manifestation of Human Immunodeficiency Virus infection. Arch. Neurol. 44:65–9, 1987.
Parry G.:Peripheral neuropathies associated with human immunodeficiency virus infection. Ann. Neurol. 23 (suppl.):S49-S53, 1988.
Portegies P., Epstein L.G., Hung, S.T.A. et al.:Human Immunodeficiency Virus type 1 antigen in cerebrospinal fluid. Correlation with clinical neurologic status. Arch. Neurol. 46:261–4, 1989.
Przedborski S., Liesnard C., Hildebrand J.:HTLV-III and vacuolar myelopathy. N. Engl. J. Med. 315:63, 1986.
Resnick L., DiMarzo-Veronese F., Schupbach J. et al.:Intra-blood-brain-barrier synthesis of HTLV-III specific IgG in patients with neurological symptoms associated with AIDS or AIDS-related complex. N. Engl. J. Med. 313:1498–504, 1985.
Resnick L., Berger J.R., Shapshak P., Tourtellotte W.W.:Early penetration of the blood-brain-barrier by HIV. Neurology 38:9–14, 1988.
Scaravilli F.:Neuropathology of HIV1 and HTLVI infection. Rudge P. (Ed) Neurological aspects of human retroviruses, Balliere Tindall Publishers. Chapter 9:211–238, 1992.
Shaunak S., Albright R.E., Klotman M.E. et al.:Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease. J. Infect. Dis. 161:1068–72, 1990.
Somma-Mauvais H., Regis H., Gastaut J.L. et al.:Potentiels Evoqués Multimodaux dans l'infection par le virus de l'Immunodeficience Humaine. Rev. Neurol. 146:196–204, 1990.
Spadaro M., Tilia G., Pinter E. et al.:Neurologic follow-up study in a group of asymptomatic HIV1 positive subjects. IV International Conference on AIDS, Volume 2:174 (abstract), 1990.
Van Wielink G., McArthur J.C., Moench T. et al.:Intrathecal synthesis of anti-HIV IgG: correlation with increasing duration of HIV infection. Neurology 40:816–9, 1990.
Author information
Authors and Affiliations
Additional information
Supported by Istituto Superiore di Sanità/Ministero della Sanità, II AIDS Research Project-1989.
Rights and permissions
About this article
Cite this article
Tilia, G., Spadaro, M., Soldati, G. et al. Predictive value of neurological abnormalities in HIV 1 patients in the early stages of the infection. Ital J Neuro Sci 14, 171–177 (1993). https://doi.org/10.1007/BF02335752
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02335752